Stock EMH EMERALD HEALTH THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Emerald Health Therapeutics, Inc. Toronto S.E.

Equities

EMH

CA29102R1064

End-of-day quote Toronto S.E.
Other stock markets
 18:00:00 2021-05-04 EDT 		5-day change 1st Jan Change
0.235 CAD -4.08% Intraday chart for Emerald Health Therapeutics, Inc. -.--% +27.50%
2023 C3 Souvenir Holding, Inc. completed the acquisition of Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc. CI
2022 C3 Souvenir Holding, Inc. entered into a share purchase agreement to acquire Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc. for CAD 12 million. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
C3 Souvenir Holding, Inc. completed the acquisition of Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc.
Skye Bioscience, Inc. completed the acquisition of Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others.
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Emerald Health Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Emerald Health Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
Emerald Health Therapeutics, Inc. Approves Board Appointments
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Emerald Health Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
Emerald Health Therapeutics, Inc. Provides Revenue Guidance for the First Quarter 2019
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EMH Stock
  4. EMH Stock
  5. News Emerald Health Therapeutics, Inc.
  6. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW